Candel Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
CADL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
117 Kendrick Street, Suite 450, Needham, MA

Insiders trading volume in the past year

Candel Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Estuardo Aguilar-Cordova 10%+ Owner $52.5M Feb 21, 2025
Paul B. Manning Director $24.7M +$7.5M +43.6% Jun 25, 2025
Laura K. Aguilar 10%+ Owner $2.74M May 6, 2022
Christopher Martell Director $2.61M Jun 25, 2025
Paul Peter Tak Chief Executive Officer, Director $1.25M -$560K -30.9% Jun 25, 2025
Joseph C. Papa Director $483K Jun 25, 2025
Francesca Barone Chief Scientific Officer $471K -$492K -51.1% Jun 25, 2025
Seshu Tyagarajan Chief Technology Officer $424K -$499K -54% Jun 25, 2025
William Garrett Nichols Chief Medical Officer $366K -$572K -60.9% Jul 28, 2025
Charles Schoch Chief Financial Officer $203K -$195K -49% Jun 25, 2025
Jason Amello Chief Financial Officer $182K Nov 28, 2023
Udi Meirav Director $43.9K Jul 26, 2021
Smith Alan E Director $29.3K Jul 26, 2021
Gary J. Nabel Director $25K Jun 25, 2025
Nicoletta Loggia Director $10K Jun 25, 2025
John Canepa Chief Financial Officer $9.11K Feb 28, 2022
Nathan Caffo Chief Business Officer $5.4K Jul 29, 2021
Shaan-Chirag C. Gandhi Director Jul 26, 2021
Renee Gaeta Director Jun 17, 2025
Susan B. Stewart Chief Regulatory Officer Apr 11, 2022
Edward J. Benz JR Director Jun 17, 2025
Maha Radhakrishnan Director Jun 4, 2025
Diem Nguyen Director Jun 17, 2025

Recent Insider Transactions by Companies or Individuals for Candel Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.